Brief: LakeShore Biopharma Regains Compliance With Nasdaq Minimum Bid Price Requirement
29/10/2024 12:36
Oct 29 (Reuters) - LakeShore Biopharma Co Ltd H6Z0.F :
* LAKESHORE BIOPHARMA REGAINS COMPLIANCE WITH NASDAQ MINIMUM
BID
PRICE REQUIREMENT
Source text: ID:nPncfFfH1a
Further company coverage: H6Z0.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LakeShore Biopharma Co
See all newsBrief: LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Brief: Lakeshore Biopharma Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company
Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
Brief: Lakeshore Biopharma Announces Us$15 Million Private Placement Financing